Related Experiment Video
Updated: Aug 3, 2026
17:16
Registered Bioimaging of Nanomaterials for Diagnostic and Therapeutic Monitoring
Published on: December 9, 2010
Diffusion-weighted MRI and ADC mapping in FK506 neurotoxicity
1Department of Diagnostic Radiology, The Catholic University of Korea, Seoul, Korea.
The British Journal of Radiology
|January 9, 2004
Summary
FK506, an immunosuppressant, can cause neurotoxicity. Diffusion-weighted MRI revealed vasogenic edema, suggesting a key role in FK506 central nervous system toxicity pathogenesis.
Area of Science:
- Neuroscience
- Radiology
- Pharmacology
Background:
- FK506 is a potent immunosuppressant crucial for preventing organ transplant rejection.
- The pathogenic mechanisms underlying FK506-induced neurotoxicity remain unclear.
- Understanding FK506 neurotoxicity is vital for patient safety in transplantation.
Observation:
- A patient treated with FK506 exhibited central nervous system toxicity.
- Imaging revealed increased signal intensities in the parieto-occipital lobes on T2-weighted, diffusion-weighted images, and ADC maps.
- These imaging findings were consistent with edema in specific brain regions.
Findings:
- Diffusion-weighted MRI and ADC mapping were utilized to investigate FK506 neurotoxicity.
- The study identified characteristic imaging patterns associated with FK506-induced central nervous system toxicity.
- Findings suggest vasogenic edema, not cytotoxic edema, is implicated in FK506 neurotoxicity.
Implications:
- This research clarifies a potential mechanism of FK506 neurotoxicity.
- The findings may guide the diagnosis and management of FK506-related neurological side effects.
- Further research can explore therapeutic strategies targeting vasogenic edema in FK506-treated patients.
